Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Celgene Ab
OY
Dissolved
Y-tunnus 2095939-0
Äyritie 18, 01510
Vantaa
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2007 · 19 years old
— employees
www.celgene.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Celgene Ab
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AK
Anna Katarina Edsfors Äleskog
Deputy Member
Deputy Member
2022
EM
Evristhenis Michalopoulos
Chief Executive Officer
Chief Executive Officer
2023
Former (4)
EM
Evristhenis Michalopoulos
Chief Executive Officer
Chief Executive Officer
2022 – 2023
SB
Simone Böhrer
Chief Executive Officer
Chief Executive Officer
2020 – 2022
JR
Jani Roger Mantila
Audit
Audit
2021 – 2023
KJ
Kim Johan Järvi
Audit
Audit
2012 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JB
Jörg Boris Schulze
Board of Directors
Board of Directors
2023
AC
Abdelhamid Chaaibi
Board of Directors
Board of Directors
2022
Former (10)
NS
Nakisa Serry
Board of Directors
Board of Directors
2018 – 2020
SM
Swati Mehta
Board of Directors
Board of Directors
2020 – 2022
PE
Patrick Eugene Flanigan III
Board of Directors
Board of Directors
2018 – 2019
HM
Hilde Mangseth Bech
Chairperson
Chairperson
2022 – 2022
KR
Katherine Reynolds Kelly
Chairperson
Chairperson
2019 – 2021
SJ
Stéphane Jacques C. Strebelle
Board of Directors
Board of Directors
2022 – 2022
DW
David Walter Pignolet
Board of Directors
Board of Directors
2018 – 2021
IL
Iddo Leshem
Board of Directors
Board of Directors
2021 – 2022
MG
Michaël Guislain Lugez
Chairperson
Chairperson
2018 – 2019
TT
Tuomo Tapani Pätsi
Board of Directors
Board of Directors
2018 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Celgene Ab
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network